Revised transaction expands NexTel’s acquisition from JumpstartRx and NuevistraMed to Island 40 Group’s broader growth platform, adding health services, pharmaceutical access, lab testing, institutional partnerships, and diversified revenue channels
Read more at globenewswire.comNexTel Medical Corp. Amends Previously Announced Acquisition to Acquire Island 40 Group and Full Subsidiary Platform
Barchart·07/22/2026 11:16:00
語音播報
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.